Repros Therapeutics Inc (NASDAQ:RPRX)

Data as of 3:59pm ET
 -0.17 / -2.00%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Repros Therapeutics, Inc. is a development stage biopharmaceutical company focused on the development of small molecule drugs for major unmet medical needs that treat male and female reproductive disorders. The company's current product pipeline consists of Androxal, Proellex, Vasomax and Z-Max. Repros Therapeutics was founded on August 28, 1987 and is headquartered in Woodlands, TX.

Contact Information

Repros Therapeutics, Inc.
2408 Timberloch Place
Woodlands Texas 77380
P:(281) 719-3400
Investor Relations:



Individual stakeholders9.21%
Other institutional52.01%
Mutual fund holders32.08%

Top Executives

Joseph S. PodolskiPresident, Chief Executive Officer & Director
Katherine A. AndersonSecretary, Chief Financial & Accounting Officer
Ronald D. WiehleVice President-Research & Development
Jaye L. ThompsonSenior Vice President-Clinical & Regulatory
Joachim F. WernickeChief Medical Officer

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.